Literature DB >> 4008672

Objectively measured hyperactivity--II. Caffeine and amphetamine effects.

M D Schechter, G D Timmons.   

Abstract

Errors of commission and omission, chair movements, and reaction times were assessed in fifteen previously diagnosed hyperactive children on a Continuous Performance Test after four drug regimens: amphetamine at doses of 1.6 and 5.0 mg twice a day, as well as 300 mg caffeine administered alone and with 1.6 mg amphetamine twice a day, produced significant reductions in errors of commission and increased reaction times in those children scoring 24 or more on the Conner's Abbreviated Parent Questionnaire. In addition, subjective symptoms on this questionnaire were significantly reduced by all drug treatments. The high (600 mg) daily dose of caffeine was observed to significantly control hyperactive symptoms, however, it also produced a number of side effects as well.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008672     DOI: 10.1002/j.1552-4604.1985.tb02838.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  2 in total

1.  Oral and intravenous caffeine for treatment of children with post-sedation paradoxical hyperactivity.

Authors:  Joan T Rubin; Richard B Towbin; MaryBeth Bartko; Kevin M Baskin; Anne Marie Cahill; Robin D Kaye
Journal:  Pediatr Radiol       Date:  2004-09-08

Review 2.  The therapeutic potential of exercise and caffeine on attention-deficit/hyperactivity disorder in athletes.

Authors:  Abigail S Sogard; Timothy D Mickleborough
Journal:  Front Neurosci       Date:  2022-08-12       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.